Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: a systematic review and meta-analysis.

about

CGManalyzer:an R package for analyzing continuous glucose monitoring studies.

P2860

Q47190283-98A81B8E-9450-4670-A6AA-796947477087

P2860

Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q36124544

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Differential HbA1c response in ...... atic review and meta-analysis.

@ast

Differential HbA1c response in ...... atic review and meta-analysis.

@en

type

Item

label

Differential HbA1c response in ...... atic review and meta-analysis.

@ast

Differential HbA1c response in ...... atic review and meta-analysis.

@en

prefLabel

Differential HbA1c response in ...... atic review and meta-analysis.

@ast

Differential HbA1c response in ...... atic review and meta-analysis.

@en

P1476

Differential HbA1c response in ...... atic review and meta-analysis.

@en

P2093

Chun Shan

http://www.w3.org/2001/XMLSchema#string

Lingyu He

http://www.w3.org/2001/XMLSchema#string

Shu Liu

http://www.w3.org/2001/XMLSchema#string

Xiaohua Douglas Zhang

http://www.w3.org/2001/XMLSchema#string

Yingmei Tu

http://www.w3.org/2001/XMLSchema#string

Zhengqing Li

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Bias in meta-analysis detected by a simple, graphical test

Quantifying heterogeneity in a meta-analysis

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus

Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study

Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks.

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes.

Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes

Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus.

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone

P2888

s40360-016-0084-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1186/S40360-016-0084-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1035668761

http://www.w3.org/2001/XMLSchema#string

P698

27600598

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

mechanism of action

blood proteins

biomedical investigative technique

hemeprotein

P932

5013632

http://www.w3.org/2001/XMLSchema#string

Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: a systematic review and meta-analysis.

about

P2860

P2860

Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: a systematic review and meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932